Tilkynningar fyrirtækja · 13.11.20261 min read
HTL Biotechnology launches HTL8, a production unit dedicated to pharmaceutical-grade polynucleotides (DNA)
Staðbundin vélþýðing · Upprunalegt tungumál heimildar
Summary
JAVENÉ, France, Nov. 13, 2026 — Thursday, November 12, HTL Biotechnology, a world leader in the development and production of pharmaceutical-grade biopolymers, inaugurated its new production unit,…
Upprunalegt tungumál heimildar: PR Newswire UK — News ReleasesOpna upprunalega tilkynningu →